Derek J. Williams

Derek J. Williams

Auto-generated profile, based on publicly available information

Derek J. Williams

Department of Pediatrics, Division of Hospital Medicine Vanderbilt University Medical Center Nashville Tennessee USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2022 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
DWDerek J. Williams
Derek J. Williams
CCC. Buddy Creech
C. Buddy Creech
EWEmmanuel B. Walter
Emmanuel B. Walter
JMJudith M. Martin
Judith M. Martin
JGJeffrey S. Gerber
Jeffrey S. Gerber
TTThe DMID 14-0079 Study Team
The DMID 14-0079 Study Team
Community-acquired pneumonia (CAP), one of the most common serious infections in childhood, is responsible for approximately 1.5 million ambulatory visits in children annually in the US.1 Professional society guidelines recommend 10 days of antibiotic therapy for outpatient CAP but acknowledge that shorter courses of therapy may be equally effective.2 Limiting antibiotic use to the shortest possible effective duration is critical to reducing adverse effects of antibiotic treatment and the spread of antimicrobial resistance.3,4 Several randomized clinical trials have demonstrated noninferiority of shorter treatment durations in children,5,6 including a recent trial in Canada7 that found that 5 days of amoxicillin therapy was noninferior to 10 days for treatment of CAP in children younger than 10 years. However, these studies were designed as noninferiority efficacy trials and did not comprehensively consider potential antibiotic-associated adverse effects, an important patient-centered outcome that impacts patient experience, treatment adherence, and efficacy. None of the aforementioned studies examined potential associations between treatment duration and its impact on the reservoir of antibiotic resistance genes in the respiratory tract microbiome (ie, the resistome).2,8

17 May 2017 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ABAnna M. Bramley
Anna M. Bramley
CRCarrie Reed
Carrie Reed
LFLyn Finelli
Lyn Finelli
WSWesley H. Self
Wesley H. Self
KAKrow Ampofo
Krow Ampofo
FTfor the Centers for Disease Control and Prevention Etiology of Pneumonia in the Community (EPIC) Study Team
for the Centers for Disease Control and Prevention Etiology of Pneumonia in the Community (EPIC) Study Team
The effect of body mass index (BMI) on community-acquired pneumonia (CAP) severity is unclear. We investigated the relationship between BMI and CAP outcomes (hospital length of stay [LOS], intensive care unit [ICU] admission, and invasive mechanical ventilation) in hospitalized CAP patients from the Centers for Disease Control and Prevention Etiology of Pneumonia in the Community (EPIC) study, adjusting for age, demographics, underlying conditions, and smoking status (adults only). Compared with normal-weight children, odds of ICU admission were higher in children who were overweight (adjusted odds ratio [aOR], 1.7; 95% confidence interval [CI], 1.1–2.8) or obese (aOR, 2.1; 95% CI, 1.4–3.2), and odds of mechanical ventilation were higher in children with obesity (aOR, 2.7; 95% CI, 1.3–5.6). When stratified by asthma (presence/absence), these findings remained significant only in children with asthma. Compared with normal-weight adults, odds of LOS >3 days were higher in adults who were underweight (aOR, 1.6; 95% CI, 1.1–2.4), and odds of mechanical ventilation were lowest in adults who were overweight (aOR, 0.5; 95% CI, .3–.9). Children who were overweight or obese, particularly those with asthma, had higher odds of ICU admission or mechanical ventilation. In contrast, adults who were underweight had longer LOS. These results underscore the complex relationship between BMI and CAP outcomes.

31 October 2018 in Journal of Hospital Medicine
Verified
Journal Article
Open access
PDF file
JFJennifer M. Frush
Jennifer M. Frush
YZYuwei Zhu
Yuwei Zhu
KEKathryn M. Edwards
Kathryn M. Edwards
CGCarlos G. Grijalva
Carlos G. Grijalva
ITIsaac P. Thomsen
Isaac P. Thomsen
DWDerek J. Williams
Derek J. Williams
Within a cohort of >2,000 children hospitalized with community‐acquired pneumonia, staphylococcal pneumonia was rare (1%) but associated with adverse in‐hospital outcomes. Despite this low prevalence, use of antistaphylococcal antibiotics was common (24%). Efforts are needed to minimize overuse of antistaphylococcal antibiotics while also ensuring adequate treatment for pathogen‐specific diseases.

6 March 2020 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
HGHannah G. Griffith
Hannah G. Griffith
KDKeerti Dantuluri
Keerti Dantuluri
CTCary Thurm
Cary Thurm
DWDerek J. Williams
Derek J. Williams
RBRitu Banerjee
Ritu Banerjee
CGCarlos G. Grijalva
Carlos G. Grijalva
Objective: To characterize the prevalence of and seasonal and regional variation in inpatient antibiotic use among hospitalized US children in 2017–2018.Design: We conducted a cross-sectional examination of hospitalized children. The assessments were conducted on a single day in spring (May 3, 2017), summer (August 2, 2017), fall (October 25, 2017), and winter (January 31, 2018). The main outcome of interest was receipt of an antibiotic on the study day.Setting: The study included 51 freestanding US children’s hospitals that participate in the Pediatric Health Information System (PHIS).Patients: This study included all patients <18 years old who were admitted to a participating PHIS hospital, excluding patients who were admitted solely for research purposes.Results: Of 52,769 total hospitalized children, 19,174 (36.3%) received antibiotics on the study day and 6,575 of these (12.5%) received broad-spectrum antibiotics. The overall prevalence of antibiotic use varied across hospitals from 22.3% to 51.9%. Antibiotic use prevalence was 29.2% among medical patients and 47.7% among surgical patients. Although there was no significant seasonal variation in antibiotic use prevalence, regional prevalence varied, ranging from 32.7% in the Midwest to 40.2% in the West (P< .001). Among units, pediatric intensive care unit patients had the highest prevalence of both overall and broad-spectrum antibiotic use at 58.3% and 26.6%, respectively (P< .001).Conclusions: On any given day in a national network of children’s hospitals, more than one-third of hospitalized children received an antibiotic, and 1 in 8 received a broad-spectrum antibiotic. Variation across hospitals, setting and regions identifies potential opportunities for enhanced antibiotic stewardship activities.

2 February 2023 in The Journal of Pediatrics
Verified
Journal Article
Closed access
SASandra R. Arnold
Sandra R. Arnold
SJSeema Jain
Seema Jain
DDDavid Dansie
David Dansie
HKHerman Kan
Herman Kan
DWDerek J. Williams
Derek J. Williams
RKRobert A. Kaufman
Robert A. Kaufman

12 April 2023 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
DWDerek J. Williams
Derek J. Williams
JMJudith M. Martin
Judith M. Martin
HNHui Nian
Hui Nian
AWAsli O. Weitkamp
Asli O. Weitkamp
JSJason Slagle
Jason Slagle
CGCarlos G. Grijalva
Carlos G. Grijalva